Allan W. May is a Founder and Chairman of Life Science Angels, the largest angel organization in the U.S. focused solely on early stage medical device and life science start-ups, and comprised solely of high net worth individuals from the medical device or biotech fields. LSA has invested over $45M in 43 startups and achieved 7 positive exits to date. In 2011, Allan launched the Life Science Angel Network, a consortium of 15 angel groups throughout the United States, to focus on increasing the syndication and capitalization of highly vetted healthcare startups.
In 2007, Allan joined renowned inventor, entrepreneur and cardiac surgeon, Dr. Thomas Fogarty, in co-founding Emergent Medical Partners, a venture fund focused on early stage medical device company creation and investing. EMP has invested $55M in 28 startups with 8 positive exits to date.
Allan is a member of the board of both the Kauffman Foundation’s Angel Capital Association and Angel Resource Institute. Until mid-2012, Allan was Chair of ARI, a nonprofit devoted to the promotion and study of angel investing. He was instrumental in the creation of the Halo Report, the first detailed data tracking early stage investment by angel groups.
Since 1995, Allan has been founder, Chairman, CEO, or investor in over 50 medtech, biotech, and diagnostic startups. He has led the business section of Singularity University’s FutureMed program, and speaks frequently at universities, conferences and government programs on trends and developments affecting early stage biotech and medtech investing. Allan is also a member of the boards of the Open Medicine Institute and Vascular Cures, and a member of the advisory board of the UCSF Entrepreneurship Center.